Fig. 2. AMRs of Acinetobacter baumannii in various clinical conditions. (A) CA versus HA, (B) ICU versus non-ICU-admitted patients, (C) inpatients versus outpatients. *Statistically significant (P-value < 0.05). Abbreviations: AMR, antimicrobial resistance rates; CA, communityacquired infection; HA, healthcare-associated infection; ICU, intensive care unit; PIP, piperacillin; TZP, piperacillin-tazobactam; SAM, ampicillin-sulbactam; CAZ, ceftazidime; FEP, cefepime; IPM, imipenem; MEM, meropenem; AMK, amikacin; GEN, gentamicin; TOB, tobramycin; CIP, ciprofloxacin; MIN, minocycline; TGC, tigecycline; CST, colistin